Performance of the Acoustic Based CADScor System in Coronary Artery Disease

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
INTEGRIS Baptist Medical Center
Study ID
NCT06655779
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Angina (stable)
  • Coronary Artery Disease

Eligibility Criteria

Sex
ALL
Age
30 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Acoustic Detection of Blood Flow — DIAGNOSTIC_TEST
    Subject will have the acoustic device scoring performed prior to a Coronary CTA. No treatment decisions will be based upon the acoustic device score.

Study Details

The purpose of this study is to determine if the CAD Score, collected from the CADscore system, performs as well as the Coronary CTA in determining Coronary Artery Disease, in low to intermediate risk patients that are referred for coronary CTA.

Key Dates

Start date
Nov 30, 2024
Status verified
Oct 2024
Primary completion
Dec 31, 2025
Completion
Mar 31, 2026

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Primary Objective [ Time Frame: From enrollment through 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
INTEGRIS Baptist Medical CenterOklahoma CityOklahoma73112
Jill Fife, RN
405-951-8607
Linda Pitchford, RN, APRN
405-949-3648
Jon p Blaschke, MD

Find similar trials in Oklahoma City, OK

Related Studies